Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms in IGF2 Induced Chemoresistance and Mitochondrial Regulation in Triple Negative Breast Cancer

NCT04266353 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT04266353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04266353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms in IGF2 Induced Chemoresistance and Mitochondrial Regulation in Triple Negative Breast Cancer
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Withdrawn
Start date
April 24, 2019
Completion date
August 22, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemoprevention